DOCSLIB.ORG

華潤集團(創業)有限公司 (Stock Code: 291) CRH (Enterprise) Limited (Incorporated in BVI with Limited Liability)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
華潤集團(創業)有限公司 (Stock Code: 291) CRH (Enterprise) Limited (Incorporated in BVI with Limited Liability) THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION If you are in any doubt as to any aspect of this Revised Partial Offer, this Composite Document or as to the action to be taken, you should consult a licensed securities dealer or registered institution in securities, bank manager, solicitor, professional accountant or other professional advisor. If you have sold or transferred all your securities in China Resources Beer (Holdings) Company Limited, you should at once hand this Composite Document and the accompanying Form of Acceptance to the purchaser(s) or transferee(s), licensed securities dealer or registered institution in securities, or other agent through whom the sale or transfer was effected for transmission to the purchaser(s) or transferee(s). This Composite Document should be read in conjunction with the accompanying Form of Acceptance, the contents of which form part of the terms and conditions of the Revised Partial Offer. The Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited and Hong Kong Securities Clearing Company Limited take no responsibility for the contents of this Composite Document and the accompanying Form of Acceptance, make no representation as to their accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Composite Document and the accompanying Form of Acceptance. (Incorporated in Hong Kong with limited liability) (Incorporated in Hong Kong with limited liability) 華潤集團(創業)有限公司 (Stock Code: 291) CRH (Enterprise) Limited (Incorporated in BVI with limited liability) COMPOSITE OFFER AND RESPONSE DOCUMENT REVISED VOLUNTARY UNCONDITIONAL CASH PARTIAL OFFER BY MERRILL LYNCH (ASIA PACIFIC) LIMITED AND MORGAN STANLEY ASIA LIMITED ON BEHALF OF CRH (ENTERPRISE) LIMITED TO ACQUIRE UP TO 484,273,072 SHARES IN THE CAPITAL OF CHINA RESOURCES BEER (HOLDINGS) COMPANY LIMITED (REPRESENTING APPROXIMATELY 20 PER CENT. OF ITS ISSUED SHARE CAPITAL) FROM QUALIFYING SHAREHOLDERS Financial Advisors to the Offeror Financial Advisor to the Company Independent Financial Advisor to the Independent Board Committee and the Independent Shareholders Shareholders should inform themselves of and observe any applicable legal or regulatory requirements. See “Important Notice” beginning on page iii of this Composite Document, “Overseas Shareholders” in the letter from BofAML and Morgan Stanley and Appendix I to this Composite Document beginning on page 14 and page I-12 of this Composite Document, respectively. Capitalised terms used in this cover page have the same meaning as those defined in the section headed “Definitions” in this Composite Document. A letter from BofAML and Morgan Stanley containing, among other things, the details of the terms and conditions of the Revised Partial Offer is set out on pages 9 to 19 of this Composite Document. A letter from the Board is set out on pages 20 to 25 of this Composite Document. A letter from the Independent Board Committee containing its recommendation to the Independent Shareholders in respect of the Revised Partial Offer is set out on pages 26 to 27 of this Composite Document. A letter from Rothschild, the Independent Financial Advisor, containing its advice to the Independent Board Committee and the Independent Shareholders in respect of the Revised Partial Offer is set out on pages IFA-1 to IFA-18 of this Composite Document. The procedures for acceptance and settlement of the Revised Partial Offer are set out in Appendix I to this Composite Document and in the accompanying Form of Acceptance. Acceptances of the Revised Partial Offer should be received by the Share Registrar by no later than 4:00 p.m. on Wednesday, 2 December 2015, being the Closing Date. Any persons including, without limitation, custodians, nominees and trustees, who would, or otherwise intend to, forward this Composite Document and/or the accompanying Form of Acceptance to any jurisdiction outside of Hong Kong should read the section headed “Overseas Shareholders” in the letter from BofAML and Morgan Stanley and Appendix I to this Composite Document before taking any action. It is the responsibility of each overseas Qualifying Shareholder wishing to accept the Revised Partial Offer to satisfy himself, herself or itself as to full observance of the laws of the relevant jurisdiction in connection therewith, including the obtaining of any governmental, exchange control or other consents which may be required and the compliance with other necessary formalities or legal requirements. Overseas Qualifying Shareholders are advised to seek professional advice on deciding whether to accept the Revised Partial Offer. 30 October 2015 CONTENTS Page Expected Timetable ............................................... ii Important Notice ................................................. iii Definitions ..................................................... 1 Letter from BofAML and Morgan Stanley ............................. 9 Letter from the Board ............................................. 20 Letter from the Independent Board Committee ......................... 26 Letter from the Independent Financial Advisor ........................ IFA-1 Appendix I – Further Terms of the Revised Partial Offer ............ I-1 Appendix II – Financial Information of the Group .................. II-1 Appendix III – Property Valuation Report .......................... III-1 Appendix IV – Financial Information of CRH ....................... IV-1 Appendix V – General Information .............................. V-1 Accompanying document – Form of Acceptance –i– EXPECTED TIMETABLE The timetable set out below is indicative only and any changes to the timetable will be jointly announced by CRH, the Offeror and the Company. Despatch date of this Composite Document and the accompanying Form of Acceptance (Note 1) ............Friday, 30 October 2015 Revised Partial Offer open for acceptance ..................Friday, 30 October 2015 Latest time and date for acceptance of the Revised Partial Offer on the Closing Date (Notes 1, 2 and 3) .....................4:00 p.m. on Wednesday, 2 December 2015 Closing Date (Note 1) ..............................Wednesday, 2 December 2015 Announcement of the results of the Revised Partial Offer to be posted on the website of the Stock Exchange (Note 3) ..............nolater than 7:00 p.m. on Wednesday, 2 December 2015 Latest date for posting of remittances for amounts due under the Revised Partial Offer in respect of the Shares tendered for acceptance and taken up by the Offeror (Note 4) ...................Friday, 11 December 2015 Notes 1. The Revised Partial Offer, which is unconditional in all respects, is made on the date of posting of this Composite Document and is capable of acceptance on and from that date until the Closing Date. Acceptances of the Revised Partial Offer shall be irrevocable and not capable of being withdrawn, except in the circumstances set out in the section headed “Irrevocable acceptances” in Appendix I to this Composite Document. 2. In accordance with the Code, the Revised Partial Offer must initially be open for acceptance for at least, and may not be extended beyond, 21 days following the date on which this Composite Document is posted. However, in order to comply will relevant US securities laws which requires the Revised Partial Offer to open for at least 20 US Business Days, the Revised Partial Offer will close for acceptances at 4:00 p.m. on Wednesday, 2 December 2015. Beneficial owners of Shares who hold their shares in CCASS directly as an investor participant or indirectly via a broker or custodian participant should note the timing requirements (set out in Appendix I) for causing instructions to be made to CCASS in accordance with the General Rules of CCASS and CCASS Operational Procedures. 3. An announcement will be issued through the website of the Stock Exchange by 7:00 p.m. on Wednesday, 2 December 2015 stating whether the Revised Partial Offer has been revised or expired. 4. Remittances in respect of the Shares tendered for acceptance and taken up by the Offeror under the Revised Partial Offer (after deducting the seller’s ad valorem stamp duty arising therefrom and, if applicable, the fees payable to the Share Registrar in respect of lost or unavailable Share certificates) will be posted to the relevant Qualifying Shareholders by ordinary post at their own risk as soon as possible, but in any event within seven business days (as defined in the Code) of the Closing Date. All references to times and dates contained in this Composite Document are to Hong Kong times and dates. –ii– IMPORTANT NOTICE NOTICE TO US SHAREHOLDERS The Revised Partial Offer is being made for the securities of a Hong Kong company and is subject to Hong Kong disclosure requirements, which are different from those of the United States. The financial information included in this Composite Document has been prepared in accordance with Hong Kong Financial Reporting Standards and thus may not be comparable to financial information of US companies or companies whose financial statements are prepared in accordance with generally accepted accounting principles in the United States. The Revised Partial Offer will be made in the United States pursuant to the applicable US tender offer rules and otherwise in accordance with the requirements of the SFO. Accordingly, the Revised Partial Offer will be subject to disclosure and other procedural requirements,
Load more

Recommended publications
  • <I>Anemone Raddeana</I>
    REVIEW Pharmacochemistry & Biomacromolecule Research Laboratories1, Qiqihar Medical University, Qiqihar; College of Pharmacy2, Changchun University of Chinese Medicine, Changchun, P. R.China Phytochemicals and bioactivities of Anemone raddeana Regel: a review Yong-Xu Sun 1,∗, Ji-Cheng Liu 1,∗, Da-You Liu 2,∗ Received April 28, 2011, accepted May 27, 2011 Ji-Cheng Liu, Qiqihar Medical University, 333 BuKui Street, JianHua District, Qiqihar, 161006, China [email protected] Da-YouLiu, College of Pharmacy, Changchun University of Chinese Medicine, 1035 BoShuo Road, Jing Yue Economic Development District, Changchun, 130117, China [email protected] Yong-Xu Sun, Pharmacochemistry & Biomacromolecule Research Laboratories, Qiqihar Medical University, 333 BuKui Street, JianHua District, Qiqihar, 161006, China [email protected] ∗These authors contributed equally to this work. Pharmazie 66: 813–821 (2011) doi: 10.1691/ph.2011.1574 Anemone raddeana, usually called as “ToujianLiang” in China, is an Anemone herb belonging to the Ranun- culaceae family. Until now there are in total 67 of chemical components identified including triterpenoids, steroids, lactones, fats and oils, saccharide and alkaloids. A broad spectrum of pharmacological activity of A. raddeana compounds have been reported, such as antitumor, antimicrobial, anti-inflammatory, sedative and analgesic activites, as well as anti-convulsant and anti-histamine effects. In view of this, we initiated this short review to present the phytochemical and pharmacological profile of A. raddeana to support future studies in this discipline. 1. Introduction Anemone raddeana Regel is a traditional Chinese medicinal herb belonging to the Anemone genus (Ranunculaceae), which is widely distributed in Russia (Far east), northeast of China, Japan and Korea (Chen et al.
    [Show full text]
  • STOXX EMERGING MARKETS 800 LO Selection List
    STOXX EMERGING MARKETS 800 LO Last Updated: 20200901 ISIN Sedol RIC Int.Key Company Name Country Currency Component FF Mcap (BEUR) Rank (FINAL)Rank (PREVIOUS) TW0002330008 6889106 2330.TW TW001Q TSMC TW TWD Y 295.1 1 1 KR7005930003 6771720 005930.KS KR002D Samsung Electronics Co Ltd KR KRW Y 195.5 2 2 INE002A01018 6099626 RELI.BO IN0027 Reliance Industries Ltd IN INR Y 77.8 3 3 INE040A01034 BK1N461 HDBK.BO IN00CH HDFC Bank Ltd IN INR Y 58.5 4 7 CNE1000002H1 B0LMTQ3 0939.HK CN0010 CHINA CONSTRUCTION BANK CORPCN H HKD Y 57.8 5 4 ZAE000015889 6622691 NPNJn.J ZA004D Naspers Ltd ZA ZAR Y 57.3 6 5 CNE1000003X6 B01FLR7 2318.HK CN0076 PING AN INSUR GP CO. OF CN 'H' CN HKD Y 51.5 7 6 INE009A01021 6205122 INFY.BO IN006B Infosys Ltd IN INR Y 41.6 8 8 RU0009024277 B59SNS8 LKOH.MM EV020 LUKOIL RU RUB Y 38.9 9 9 KR7035420009 6560393 035420.KS KR00NY NAVER CORP KR KRW Y 37.4 10 12 BRVALEACNOR0 2196286 VALE3.SA BR0024 Vale SA BR BRL Y 34.3 11 10 INE001A01036 6171900 HDFC.BO IN00EJ Housing Development Finance Co IN INR Y 34.1 12 13 CNE1000003G1 B1G1QD8 1398.HK CN0021 ICBC H CN HKD Y 33.2 13 11 HK0941009539 6073556 0941.HK 607355 China Mobile Ltd. CN HKD Y 32.6 14 15 KR7000660001 6450267 000660.KS KR00EP SK HYNIX INC KR KRW Y 30.8 15 14 INE467B01029 B01NPJ1 TCS.BO IN005A Tata Consultancy Services Ltd IN INR Y 26.9 16 18 TW0002317005 6438564 2317.TW TW002R Hon Hai Precision Industry Co TW TWD Y 26.4 17 17 INE090A01021 BSZ2BY7 ICBK.BO IN00BG ICICI Bank Ltd IN INR Y 26.3 18 22 RU0009029540 4767981 SBER.MM EV023 SBERBANK RU RUB Y 26.1 19 19 TW0002454006 6372480
    [Show full text]
  • Marketing Holdings Report
    Driehaus Emerging Markets Opportunities Fund (Unaudited) Security Portfolio for 12/31/2020 Quantity ID Security Description Market Value ARGENTINA 779,514.10 1,188 GLOB GLOBANT SA 258,520.68 311 MELI MERCADOLIBRE INC 520,993.42 BRAZIL 3,469,892.11 9,387 AZUL AZUL SA 214,211.34 1,500,000 ZP2084801 BNTNF 10 01/01/31 350,434.62 200,000 105756CA6 BRAZIL 4 1/2 05/30/29 222,524.00 500,000 105756BZ2 BRAZIL 4 5/8 01/13/28 560,005.00 79,977 GGB GERDAU SA -SPON ADR 373,492.59 108,578 LOGG3 BZ LOG COMMERCIAL PROPERTIES E 719,349.78 40 MGLU3 BZ MAGAZINE LUIZA SA 191.81 6,724 PAGS PAGSEGURO DIGITAL LTD-CL A 382,461.12 103,212 PETZ3 BZ PET CENTER COMERCIO E PARTIC 378,668.12 18,388 WEGE3 BZ WEG SA 268,553.73 CANADA 635,019.44 11,626 BLDP BALLARD POWER SYSTEMS INC 272,048.40 8,696 WPM WHEATON PRECIOUS METALS CORP 362,971.04 CAYMAN ISLANDS 693,582.54 300,000 BK4590505 BANORT 8 3/8 PERP 358,128.00 5,451 BEKE KE HOLDINGS INC 335,454.54 CHINA 11,943,072.89 28,500 9988 HK ALIBABA GROUP HOLDING LTD 855,097.41 2,174 BABA ALIBABA GROUP HOLDING-SP ADR 505,955.02 3,315 BILI BILIBILI INC-SPONSORED ADR 284,161.80 7,000,000 BJ4697907 CGB 2.68 05/21/30 1,027,243.95 1,200,000 AM7831903 CGB 3.2 03/16/24 185,149.41 2,500,000 AT9654381 CGB 3.54 08/16/28 395,132.53 193,600 3908 HK CHINA INTERNATIONAL CAPITA-H 524,427.76 37,700 3968 HK CHINA MERCHANTS BANK-H 238,285.96 4,937 601888 C1 China Tourism Group Duty Free 213,226.04 9,195 300750 C2 CONTEMPORARY AMPEREX TECHN-A 493,662.87 108,354 300059 C2 EAST MONEY INFORMATION CO-A 513,620.29 35,200 002074 C2 GOTION HIGH-TECH
    [Show full text]
  • Assessment of Thyroid Function in Children, Adults and Pregnant and Lactating Women After Long-Term Salt Iodisation Measurements
    Downloaded from British Journal of Nutrition (2018), 119, 1245–1253 doi:10.1017/S0007114518000570 © The Authors 2018 https://www.cambridge.org/core Assessment of thyroid function in children, adults and pregnant and lactating women after long-term salt iodisation measurements Xiaohui Su1,MuLi2, Lixiang Liu1, Hongmei Shen1, Patrick J. Kelly2, Yanling Wang3, Zhihui Chen4, . IP address: Jinbiao Wang5, Weidong Li6,HuixinChen7, Bangzhong Xiao8, Yunfeng Han9, Shoujun Liu1* and Peng Liu1* 1Key Lab of Etiology and Epidemiology, Education Bureau of Heilongjiang Province & Ministry of Health, Center for Endemic 170.106.40.139 Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, No. 157 Baojian Road, Nangang District, Harbin 150081, People’s Republic of China 2Sydney School of Public Health, China Studies Centre, The University of Sydney, Sydney 2006, Australia 3 Center for Disease Control of Gansu Province, No. 93 Duanjiatan Road, Lanzhou 730020, People’s Republic of China , on 4 Center for Disease Control of Fujian Province, No. 76 Jintai Road, Fuzhou 350001, People’s Republic of China 23 Sep 2021 at 12:16:30 5Institute for Endemic Disease Control of Shandong Province, No. 11 Yandongxin Road, Lixia District, Jinan 250014, People’s Republic of China 6Center for Disease Control of Anhui Province, Hefei Economic and Technological Development Zone (12560 Prosperous Avenue), Hefei 230061, People’s Republic of China 7The Second Institute for Endemic Disease Control of Jilin Province, No. 23 Chongqing Road, Jilin 132001, People’sRepublicofChina 8Center for Disease Control of Chongqing Municipality, No. 8 Changjiang II Road, Yuzhong District, Chongqing 400042, , subject to the Cambridge Core terms of use, available at People’s Republic of China 9Public Health School, Qiqihar Medical University, No.
    [Show full text]
  • Beer Market Insights 2014 China In-Depth Analysis of Key Brewers, Brands, Volume, Value and Segmentation Trends and Opportunities in the Beer Market
    Beer Market Insights 2014 China In-depth Analysis of Key Brewers, Brands, Volume, Value and Segmentation Trends and Opportunities in the Beer Market www.canadean.com Sample Pages Published: June 2014 Summary The China Beer Market Insights report comprises a high level market research data on the China beer industry. The report provides readers with an excellent way of gaining a thorough understanding of the dynamics and structure of the China Beer industry. Data includes volumes from 2009 to 2013 plus 2014 forecast, enabling historical and current trend analysis. In-depth market segmentation is presented: mainstream, premium, super premium, discount, alcoholic strength, local segmentation and beer type. It also provides data and analysis of the performance of both domestic and imported brands and reports on new product activity in 2013. It presents an analysis of industry structure, and reports on company volumes, with the addition of brewer profiles for the major brewers. The report provides distribution channel data for total market (on- vs off-premise) and discusses the latest trends in the key sub-channels. Packaging data includes consumption volumes by pack material, type, size, refillable vs non-refillable, multi-serve vs single serve. Market valuation data and pricing data are also provided. Key Findings • Beer around China witnessing positive trends • Exports increase in China beer, Tsingtao leading Chinese beer around the world • New innovation in Chinese beer contributing to the increase in sales Reasons to Buy • The China Beer Market Insight report is designed for clients needing a quality in-depth understanding of the dynamics and structure of the Beer market • The report provides a much more granular and detailed data set than our competitors.
    [Show full text]
  • 2017 Annual Report the Company Holds the Finance Permit No
    (A joint stock company incorporated in the People's Republic of China with limited liability) Stock Code: 6138 2017 Annual Report The Company holds the Finance Permit No. B0306H223010001 approved by the China Banking Regulatory Commission and has obtained the Business License (Uniform Social Credit Code: 912301001275921118) approved by Market Supervision and Administration Bureau of Harbin. The Company is not an authorised institution within the meaning of the Hong Kong Banking Ordinance (Chapter 155 of the Laws of Hong Kong), not subject to the supervision of the Hong Kong Monetary Authority, and not authorised to carry on banking/deposit-taking business in Hong Kong. Harbin Bank Co., Ltd. 1 Contents 2017 Annual Report Definitions 2 Company Profile 4 Summary of Accounting Data and Financial Indicators 10 Chairman’s Statement 14 President’s Statement 17 Report of the Board of Directors 21 Changes in Share Capital and Information on Shareholders 96 Corporate Governance Report 101 Report of the Board of Supervisors 130 Important Events 132 Directors, Supervisors, Senior Management, Employees and Organisations 144 Financial Statements 158 Documents for Inspection 288 2 Harbin Bank Co., Ltd. 2017 Annual Report Definitions Definitions Company Profile Summary of Accounting Data and Financial Indicators Chairman’s Statement President’s Statement In this report, unless the context otherwise requires, the following terms shall have the meanings set out below. “A Shares” ordinary shares with a par value of RMB1.00 per share that are proposed to be issued pursuant to the A Share Offering by the Bank, which will be applied for listing on the Shanghai Stock Exchange and subscribed and traded in RMB “A Share Offering” the Bank’s proposed initial public offering of not more than 3,666,000,000 A Shares which will be applied for listing on the Shanghai Stock Exchange “Reporting Period” or “Year” the year ended 31 December 2017 “Company” Harbin Bank Co., Ltd.
    [Show full text]
  • China Resources Pharmaceutical Group Limited 華潤醫藥集團有限公司 (Incorporated in Hong Kong with Limited Liability)
    The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of China Resources Pharmaceutical Group Limited 華潤醫藥集團有限公司 (Incorporated in Hong Kong with limited liability) WARNING The publication of this Application Proof is required by The Stock Exchange of Hong Kong Limited (the “Exchange”)/ the Securities and Futures Commission (the “Commission”) solely for the purpose of providing information to the public in Hong Kong. This Application Proof is in draft form. The information contained in it is incomplete and is subject to change which can be material. By viewing this document, you acknowledge, accept and agree with the Company, its sponsor, advisers or member of the underwriting syndicate that: (a) this document is only for the purpose of providing information about the Company to the public in Hong Kong and not for any other purposes. No investment decision should be based on the information contained in this document; (b) the publication of this document or supplemental, revised or replacement pages on the Exchange’s website does not give rise to any obligation of the Company, its sponsor, advisers or members of the underwriting syndicate to proceed with an offering in Hong Kong or any other jurisdiction.
    [Show full text]
  • Stock Select Monthly
    Stock Select Monthly March 2016 Risk Factor Top 40 up 0.75% this year Small Cap in focus In this edition: Steinhoff International Invest in one of our portfolios NV Do not have the time to actively manage your portfolio? – Let us do it for you. We have been managing wealth for our clients JSE Winners & Losers (page 3) since 1969. We have well qualified and experienced portfolio managers and analysts to Top 40 Recap (page 3) select the right shares for you. By paying a small management fee you can sit Small Cap Focus (page 16) back and relax and see your money grow. Contact us on 011-3751000 or mail us on [email protected] to find out more. Please refer to the disclaimer at the end of this document 1 Stock Select Monthly – March 2016 Table of Contents Executive Summary JSE Winners and Losers 3 Welcome to the March 2016 edition of Stock Select Monthly, a monthly publication produced by Thebe Stockbroking for our private clients. Top 40 Key Events and Results 3 The JSE All Share Index closed 5.74% higher in March supported by strong JSE Indices Performance 5 performances in platinum and financial shares. Platinum shares were the best performers during March, rising as a group by 24.98% followed by Top 40 Focus 6 banking shares that gained 13.43%. Platinum shares benefitted from increased demand for the metal - the platinum price rose by more than 4% Top 40 Stock Pick Performances 6 during the month - while banking and financial shares benefitted from an increase in the repo rate.
    [Show full text]
  • The Influence of Network Propaganda Strategy on Promoting the Soft Power of Tourism Culture in Qiqihar
    2020 International Conference on Social and Human Sciences (ICSHS2020) The Influence of Network Propaganda Strategy on Promoting the Soft Power of Tourism Culture in Qiqihar Xiangkun Lia and Zhiwei Tian b * a Personnel Department, Qiqihar Medical University b Foreign Language Department, Qiqihar Medical University No.333, Bukui Street, Jianhua District, Qiqihar City, Heilongjiang Province, 161006 P.R.China a [email protected]; b *[email protected] * corresponding author Keywords: network propaganda strategy; tourism culture; soft power Abstract: as an important means to spread and infiltrate Chinese culture, tourism culture construction provides an important way to enhance the soft power of Chinese culture. The competition of urban tourism industry is increasingly fierce and the level of tourists' demand is constantly improving. Therefore, on the basis of consolidating its own tourism cultural strength, this paper intends to take the network publicity strategy as the starting point, and take the external publicity strategy of improving the soft strength of Qiqihar's tourism culture as the goal; through the research methods of literature, field investigation, comparative research, induction and summary, etc. This paper discusses how to build the brand image of the city's tourism culture soft power in Qiqihar, and summarizes the influence of the network propaganda strategy on the communication of the tourism culture soft power according to the results of the comparative study and questionnaire analysis, so as to improve the international competitiveness of the tourism culture industry. 1. Introduction Soft power is a useful inspiration to understand how policy makers and public intellectuals actively build "China" and "world" [1]. Vlassis [2] studies the importance of cultural industry in enhancing the soft power of emerging countries, and tries to understand how cultural industry enables emerging countries to shape their international environmental structure.
    [Show full text]
  • Cereal Series/Protein Series Jiangxi Cowin Food Co., Ltd. Huangjindui
    产品总称 委托方名称(英) 申请地址(英) Huangjindui Industrial Park, Shanggao County, Yichun City, Jiangxi Province, Cereal Series/Protein Series Jiangxi Cowin Food Co., Ltd. China Folic acid/D-calcium Pantothenate/Thiamine Mononitrate/Thiamine East of Huangdian Village (West of Tongxingfengan), Kenli Town, Kenli County, Hydrochloride/Riboflavin/Beta Alanine/Pyridoxine Xinfa Pharmaceutical Co., Ltd. Dongying City, Shandong Province, 257500, China Hydrochloride/Sucralose/Dexpanthenol LMZ Herbal Toothpaste Liuzhou LMZ Co.,Ltd. No.282 Donghuan Road,Liuzhou City,Guangxi,China Flavor/Seasoning Hubei Handyware Food Biotech Co.,Ltd. 6 Dongdi Road, Xiantao City, Hubei Province, China SODIUM CARBOXYMETHYL CELLULOSE(CMC) ANQIU EAGLE CELLULOSE CO., LTD Xinbingmaying Village, Linghe Town, Anqiu City, Weifang City, Shandong Province No. 569, Yingerle Road, Economic Development Zone, Qingyun County, Dezhou, biscuit Shandong Yingerle Hwa Tai Food Industry Co., Ltd Shandong, China (Mainland) Maltose， Malt Extract， Dry Malt Extract， Barley Extract Guangzhou Heliyuan Foodstuff Co.,LTD Mache Village, Shitan Town, Zengcheng, Guangzhou，Guangdong，China No.3, Xinxing Road, Wuqing Development Area, Tianjin Hi-tech Industrial Park, Non-Dairy Whip Topping\PREMIX Rich Bakery Products(Tianjin)Co.,Ltd. Tianjin, China. Edible oils and fats / Filling of foods/Milk Beverages TIANJIN YOSHIYOSHI FOOD CO., LTD. No. 52 Bohai Road, TEDA, Tianjin, China Solid beverage/Milk tea mate（Non dairy creamer）/Flavored 2nd phase of Diqiuhuanpo, Economic Development Zone, Deqing County, Huzhou Zhejiang Qiyiniao Biological Technology Co., Ltd. concentrated beverage/ Fruit jam/Bubble jam City, Zhejiang Province, P.R. China Solid beverage/Flavored concentrated beverage/Concentrated juice/ Hangzhou Jiahe Food Co.,Ltd No.5 Yaojia Road Gouzhuang Liangzhu Street Yuhang District Hangzhou Fruit Jam Production of Hydrolyzed Vegetable Protein Powder/Caramel Color/Red Fermented Rice Powder/Monascus Red Color/Monascus Yellow Shandong Zhonghui Biotechnology Co., Ltd.
    [Show full text]
  • Table of Codes for Each Court of Each Level
    Table of Codes for Each Court of Each Level Corresponding Type Chinese Court Region Court Name Administrative Name Code Code Area Supreme People’s Court 最高人民法院 最高法 Higher People's Court of 北京市高级人民 Beijing 京 110000 1 Beijing Municipality 法院 Municipality No. 1 Intermediate People's 北京市第一中级 京 01 2 Court of Beijing Municipality 人民法院 Shijingshan Shijingshan District People’s 北京市石景山区 京 0107 110107 District of Beijing 1 Court of Beijing Municipality 人民法院 Municipality Haidian District of Haidian District People’s 北京市海淀区人 京 0108 110108 Beijing 1 Court of Beijing Municipality 民法院 Municipality Mentougou Mentougou District People’s 北京市门头沟区 京 0109 110109 District of Beijing 1 Court of Beijing Municipality 人民法院 Municipality Changping Changping District People’s 北京市昌平区人 京 0114 110114 District of Beijing 1 Court of Beijing Municipality 民法院 Municipality Yanqing County People’s 延庆县人民法院 京 0229 110229 Yanqing County 1 Court No. 2 Intermediate People's 北京市第二中级 京 02 2 Court of Beijing Municipality 人民法院 Dongcheng Dongcheng District People’s 北京市东城区人 京 0101 110101 District of Beijing 1 Court of Beijing Municipality 民法院 Municipality Xicheng District Xicheng District People’s 北京市西城区人 京 0102 110102 of Beijing 1 Court of Beijing Municipality 民法院 Municipality Fengtai District of Fengtai District People’s 北京市丰台区人 京 0106 110106 Beijing 1 Court of Beijing Municipality 民法院 Municipality 1 Fangshan District Fangshan District People’s 北京市房山区人 京 0111 110111 of Beijing 1 Court of Beijing Municipality 民法院 Municipality Daxing District of Daxing District People’s 北京市大兴区人 京 0115
    [Show full text]
  • Eastern Sichuan Roads Development Project
    Report and Recommendation of the President to the Board of Directors Sri Lanka Project Number: 37490 June 2007 Proposed Loan People’s Republic of China: Eastern Sichuan Roads Development Project CURRENCY EQUIVALENTS (as of 31 May 2007) Currency Unit – yuan (CNY) CNY1.00 = $0.1308 $1.00 = CNY7.6458 The exchange rate of the yuan is determined under a floating exchange rate system. In this report, a rate of $1.00 = CNY7.73, the rate prevailing at the consultation mission for the Project, was used. ABBREVIATIONS ADB – Asian Development Bank BOT – build-operate-transfer EARD – East Asia Department EIA – environmental impact assessment EIRR – economic internal rate of return EMP – environmental management plan FIRR – financial internal rate of return HIV/AIDS – human immunodeficiency virus/acquired immunodeficiency syndrome ICB – international competitive bidding ITS – intelligent transport system JBIC – Japan Bank for International Cooperation LIBOR – London interbank offered rate MOC – Ministry of Communications NCB – national competitive bidding O&M – operation and maintenance PCR – project completion report PRC – People’s Republic of China SDAP – social development action plan SDEC – Sichuan Dashaan Expressway Company Limited STI – sexually transmitted infection PPMS – project performance management system SPCD – Sichuan Provincial Communications Department SPG – Sichuan provincial government TA – technical assistance VOC – vehicle operating costs NOTES (i) The fiscal year of the Government and its agencies ends on 31 December. (ii) In this report, "$" refers to US dollars. Vice President C. Lawrence Greenwood, Jr., Operations Group 2 Director General H. S. Rao, East Asia Department (EARD) Director N. C. Rayner, Transport Division, EARD Team leader M. Ojiro, Principal Transport Economist, EARD Team members S.
    [Show full text]